Clinical Trial Update: A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describing BIIB122 for early-stage Parkinson disease; the study is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIIB122

Snippet

Sponsor: Biogen | Conditions: Parkinson Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING